Torrent Pharmaceuticals Ltd’s shares hit a new 52-week high at ₹2,839.9, after reporting a rise in net profit by 1.4% QoQ and 57% YoY, while revenue from operations grew by 0.5% QoQ and 10.2% YoY, and the EBITDA increased by 21.4% YoY. The Board recommended a final dividend of ₹6 per equity share.